Shared Resources

man working in lab wearing a mask
Technologies to Accelerate Vaccine Research

Cores           |            Regional Biocontainment Laboratory

Cores

The faculty and senior scientific staff of the Duke Human Vaccine Institute have assembled state-of-the-art technologies into Shared Resources or Core Facilities to support research initiatives in the areas of Vaccine Immunology, Immune Reconstitution, Host Pathogen Interaction, and Emerging Infectious Disease and Biodefense. These comprehensive OPEN ACCESS Shared Resources are available to the Duke community and their collaborators.

Regional Biocontainment Laboratory

The Duke Regional Biocontainment Laboratory (RBL) was established with funding from the National Institutes of Health (NIH) to support basic research aimed at developing drugs, diagnostics, and vaccines for emerging and reemerging infections, as well as biodefense. The RBL features a comprehensive safety and operations program, providing state-of-the-art biocontainment facilities for BSL2 and BSL3 research. Since its commissioning in 2007, the RBL has received partial support for construction and renovations from the NIH (UC6-AI058607 and G20-AI167200), and facility support from the NIH (UC7-AI180254).

The Duke RBL supports basic research programs and has collaborative Core units that focus on Immunology and Virology. These units are available to Duke faculty and their collaborators as fee-for-service service centers. Through any of these units users can receive safety/security training, animal model support, and use of the containment environment. These units can be utilized separately or all together to provide comprehensive study support (regulatory compliance, study design, study execution, and data analysis).

Leadership

Director, Herman Staats, PhD

Associate Director, Scott Alderman, MS